The chief cells of CBT are frequently positive for chromogranin and Syn and negative for epithelial membrane antigen, parathyroid hormone, pancytokeratin, thyroid transcription factor, HMB-45, and renal cell carcinoma marker. This evidence concerns the gene PMEL and renal cell carcinoma.